0001209191-15-028969.txt : 20150324 0001209191-15-028969.hdr.sgml : 20150324 20150324180206 ACCESSION NUMBER: 0001209191-15-028969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150320 FILED AS OF DATE: 20150324 DATE AS OF CHANGE: 20150324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 15722796 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-20 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Policy, Access & Value Common Stock 2015-03-20 4 M 0 1468 48.74 A 91452 D Common Stock 2015-03-20 4 M 0 10532 45.11 A 101984 D Common Stock 2015-03-20 4 S 0 12000 135.08 D 89984 D Common Stock 2015-03-23 4 S 0 300 122.78 D 89684 D Common Stock 2015-03-23 4 S 0 1783 125.07 D 87901 D Common Stock 2015-03-23 4 S 0 2200 125.93 D 85701 D Common Stock 2015-03-23 4 S 0 600 127.16 D 85101 D Common Stock 2015-03-23 4 S 0 200 127.90 D 84901 D Common Stock 882 I 401(k) Stock Option (right to buy) 48.74 2015-03-20 4 M 0 1468 0.00 D 2022-07-24 Common Stock 1468 29032 D Stock Option (right to buy) 45.11 2015-03-20 4 M 0 10532 0.00 D 2023-02-04 Common Stock 10532 28593 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $122.78 (range $122.46 to $123.24). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $125.07 (range $124.56 to $125.51). Open market sales reported on this line occurred at a weighted average price of $125.93 (range $125.61 to $126.50). Open market sales reported on this line occurred at a weighted average price of $127.16 (range $126.74 to $127.72). Open market sales reported on this line occurred at a weighted average price of $127.90 (range $127.87 to $127.92). The option vests in 16 quarterly installments from 07/25/2012. The option vests in 16 quarterly installments from 02/05/2013. Omar White, Attorney-In-Fact 2015-03-24